LEO Pharma sells major product portfolio to Karo Pharma for €260m

This article was originally published here

LEO Pharma has sold product portfolio of 10 products to Swedish company Karo Pharma for €260m.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply